braces
By Francesco Guarascio and Phuong Nguyen HANOI (Reuters) – Vietnam faces trade volatility with a new Trump presidency, officials and supply chain experts told Reuters, as the country could benefit from increased U.S.-China trade tensions but may also become “collateral damage” of U.S. protectionist measures. The Southeast Asian industrial hub…
By Samuel Shen and Ryan Woo SHANGHAI/BEIJING (Reuters) -Shanghai halted transportation links, recalled ships and shut tourism spots including Shanghai Disney Resort on Sunday as it braced for Typhoon Bebinca, in what could be the strongest tropical cyclone to hit the Chinese financial hub since 1949. The Category 1 typhoon,…
By Daniel Trotta (Reuters) – Hurricane Francine threatened New Orleans and the wider Gulf Coast as far east as the Alabama and Florida border on Wednesday, shutting down a quarter of oil and gas production in the Gulf while parishes across Louisiana issued evacuation orders. Louisiana Governor Jeff Landry declared…
By Lisandra Paraguassu, Luana Maria Benedito SAO PAULO (Reuters) -An ongoing feud between a Brazil Supreme Court justice and Elon Musk left social media platform X on the brink of being blocked in the country, as President Luiz Inacio Lula da Silva demanded that the billionaire comply with local laws.…
By Anna Mehler Paperny and Nivedita Balu TORONTO (Reuters) – As Canada braced for a freight rail stoppage that could hit industries ranging from autos to agriculture, the trucking sector said it faced higher demand it could not meet. Unless labor agreements are reached, Canadian National Railway (TSX:) and Canadian…
By Leigh Thomas and Helen Reid AIX-EN-PROVENCE, France (Reuters) – France’s business elite is anxious about volatile politics, inexperienced policymakers, street protests and a possible wave of bankruptcies in the coming months, executives meeting in Provence said ahead of Sunday’s parliamentary election. Corporate leaders gathered on Friday and Saturday in…
By Andrew Silver SHANGHAI (Reuters) – Novo Nordisk (NYSE:) is facing the prospect of intensifying competition in the promising Chinese market where drugmakers are developing at least 15 generic versions of its diabetes drug Ozempic and weight loss treatment Wegovy, clinical trial records showed. The Danish drugmaker has high hopes…
